Publications by authors named "Krisztina Eszter Feher"
Article Synopsis
- Increased serum lipase levels are key indicators for diagnosing acute pancreatitis (AP), but they can also indicate non-pancreatic hyperlipasemia (NPHL) due to other health issues, complicating the diagnosis for doctors.
- This study aimed to characterize NPHL in a large cohort of patients to find clinical and lab factors that affect the accuracy of lipase diagnosis and identify potential prognostic indicators.
- The study involved 808 patients, showing that while 392 had AP, 401 had NPHL from various causes, with sepsis and acute kidney injury being the most common, leading to recommendations for better diagnostic criteria.
Background: Pseudocysts being the most frequent local complications of acute pancreatitis (AP) have substantial effect on the disease course, hospitalization and quality of life of the patient. Our study aimed to understand the effects of pre-existing (OLD-P) and newly developed (NEW-P) pseudocysts on AP.
Methods: Data were extracted from the Acute Pancreatitis Registry organized by the Hungarian Pancreatic Study Group (HPSG).
Background: Hypertriglyceridemia is the third most common cause of acute pancreatitis (AP). It has been shown that hypertriglyceridemia aggravates the severity and related complications of AP; however, detailed analyses of large cohorts are contradictory. Our aim was to investigate the dose-dependent effect of hypertriglyceridemia on AP.
View Article and Find Full Text PDFArticle Synopsis
- Researchers examined the effectiveness of C-reactive protein (CRP) and white blood cell count (WBC) in assessing acute pancreatitis (AP) through a review of existing studies and data analysis of 1435 patient episodes.
- The study found that CRP levels were not reliable indicators of mortality or severity in AP cases, with low accuracy in predictions regardless of when the levels were measured.
- However, using CRP levels within the first 24 hours after pain onset as a criterion for including patients in clinical trials significantly increased the rates of severe cases and mortality, thus potentially simplifying the patient selection process for trials.